NDMM with RI
Showing 1 - 25 of 168
Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,
Not yet recruiting
- Multiple Myeloma
- Renal Failure
- Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
-
Augusta, GeorgiaGeorgia Cancer Center-Augusta University
Nov 16, 2023
MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With
Not yet recruiting
- Multiple Myeloma
- Minimal Residual Disease
- (no location specified)
Nov 1, 2023
Multiple Myeloma Trial in Shanghai (GC012F injection)
Not yet recruiting
- Multiple Myeloma
- GC012F injection
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
May 1, 2023
Doppler-based Renal Resistive Index in Predicting Renal Recovery
Not yet recruiting
- Acute Kidney Injury
- Doppler-based renal resistive index
- (no location specified)
May 10, 2023
Multiple Myeloma Trial in Worldwide (Iberdomide, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
-
Orange, California
- +270 more
Apr 11, 2023
Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)
Not yet recruiting
- Multiple Myeloma
- idecabtagene vicleucel
- +3 more
-
Gilbert, Arizona
- +107 more
Sep 26, 2023
ZYNEX Cardiac Monitor in Patients Having Noncardiac Surgery
Not yet recruiting
- Noncardiac Surgery
- Fluid
- (no location specified)
Sep 12, 2022
Daratumumab in Combination With Bortezomib, Thalidomide, and
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
- (no location specified)
Sep 27, 2022
Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T)
Recruiting
- Multiple Myeloma
- anti-BCMA CAR-T
-
Tianjin, Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 4, 2023
OCD, Tricholemmoma, Skin-Picking Trial (Computerized cognitive training, Computerized training)
Recruiting
- Obsessive-Compulsive Disorder
- +2 more
- Computerized cognitive training
- Computerized placebo training
-
Milwaukee, WisconsinUWM Anxiety Disorders Laboratory
Dec 29, 2022
Glaucoma Trial (Oxygen)
Not yet recruiting
- Glaucoma
- Oxygen
- (no location specified)
Feb 2, 2023
Multiple Myeloma Trial in Shanghai (GC012F injection)
Recruiting
- Multiple Myeloma
- GC012F injection
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
Aug 1, 2022
Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Frailty
- (no location specified)
Oct 30, 2023
Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)
ACS - Acute Coronary Syndrome Trial in Miami (MT1002 for Injection)
Terminated
- ACS - Acute Coronary Syndrome
- MT1002 for Injection
-
Miami, FloridaPanax Clinical Research, LLC.
Jan 23, 2023
Patient and Healthcare Provider Satisfaction of Daratumumab Use
Recruiting
- Multiple Myeloma
- +5 more
- Daratumumab
-
Frankfurt, Hessen, GermanyCentrum für Hämatologie und Onkologie Bethanien
Aug 1, 2022
Post-Traumatic Stress Disorder in Children Trial in Izmir (Testing the the DSM-5 UCLA Posttraumatic Stress Disorder Reaction
Recruiting
- Post-Traumatic Stress Disorder in Children
- Testing the the DSM-5 UCLA Posttraumatic Stress Disorder Reaction Index Self-Report Scale for Children and Adolescents (PTSD-RI-5)
-
İzmir, TurkeyDr. Behcet Uz Pediatric Diseases And Surgery Training And Resear
Oct 5, 2023
Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- New Diagnosis Tumor
- Carfilzomib
- +2 more
-
Alessandria, Italy
- +41 more
Mar 24, 2022
Middle Cerebral To Umbilical Artery Doppler Ratio And Amniotic
Recruiting
- Pregnancy, Prolonged
- ultrasound and Doppler examination
-
Khamis Mushait, Afhsa, Saudi ArabiaAFHSR
Jan 30, 2022
Luo-Bu-Fu-Ke-Bi-RI Pill on Climacteric Syndrome in Women
Completed
- Climacteric Syndrome
- +2 more
- Luo-Bu-Fu-Ke-Bi-RI Pill
- tibolone
-
Chongqing, string:China, ChinaThe First Affiliated Hospital of Chongqing Medical University
May 5, 2023
Adhesive Capsulitis of Shoulder Trial (Rotator interval hydro-dissection with dextrose 5%, Rotator interval hydro-dissection
Not yet recruiting
- Adhesive Capsulitis of Shoulder
- Rotator interval hydro-dissection with dextrose 5%
- Rotator interval hydro-dissection with corticosteroid solution
- (no location specified)
Aug 2, 2023